Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers

Development of a Physiologically Based Model for Oseltamivir and Simulation of Pharmacokinetics in Neonates and Infants

(2011) Neil Parrott et al.   CLINICAL PHARMACOKINETICS

Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza

(2010) R. E. Ariano et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Early Oseltamivir Treatment of Influenza in Children 1–3 Years of Age: A Randomized Controlled Trial

(2010) Santtu Heinonen et al.   CLINICAL INFECTIOUS DISEASES

Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina

(2010) Julio A. Farias et al.   INTENSIVE CARE MEDICINE

Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States

(2010) Alicia M. Siston   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations

(2010) B. E. Davies   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

(2010) Deepali Kumar et al.   LANCET INFECTIOUS DISEASES

Outcomes of adults hospitalised with severe influenza

(2010) N. Lee et al.   THORAX

Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid

(2008) Craig R. Rayner et al.   JOURNAL OF CLINICAL PHARMACOLOGY